91AV

Synopsis

This one-day symposium will provide a platform for some of the leading names in the field of epigenetics to present their research on the underpinning biology and the discovery of novel therapeutic targets to the development of chemical probes and small molecule inhibitors. The day will comprise of a series of lectures from internationally leading scientists from both academia and industry, and a poster session for discussion and networking. The meeting will provide early stage career researchers with a fundamental understanding of epigenetics and how it relates to the frontiers of drug discovery.

Attendees

The meeting is aimed at scientists in the industrial and academic fields with a background in epigenetic chemical biology or drug discovery. It is ideally suited to those studying for a postgraduate degree or working in the pharmaceutical or biotechnology industry.

Confirmed Speakers

Prof Jian Jin, Icahn School of Medicine (Mount Sinai), New York, USA
Prof Chris Schofield FRS, University of Oxford, UK
Prof Alessio Ciulli, University of Dundee, UK
Dr Oleg Fedorov, Structural Genomics Consortium, UK
Dr Phil Humphreys, GlaxoSmithKline, UK
Dr Jon Winter, AstraZeneca, UK 
Prof John Spencer, University of Sussex, UK

Posters and Prizes

Interested applicants should send a maximum one page abstract including one figure or scheme to conferences@soci.org with the subject line 'Epigenetics 2017 - poster submission' by Friday 28 July 2017. Prizes for academic and industrial posters will be awarded.

Organising Committee

Exhibition and Sponsorship

Delegate Fees

Eli Lilly, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, United Kingdom